Senior Research Scientist at IBA with over 20 years of experience in product development in multinational companies. I graduated at the university of Liège in Belgium with a PhD in physical chemistry. I now work in the research group at IBA and I have a special interest for FLASH proton therapy. I manage different research collaborations in medical technology between IBA, universities and research institutions. I also act as a community co-manager of the open source software platform for proton therapy: https://openpath.software/

I am currently working as a Postdoctoral Researcher in the lab of Marie-Catherine Vozenin, PhD, HDR at the CHUV. I earned my BS in Molecular, Cell, and Developmental Biology at the University of California, Los Angeles in 2008. After working in the biotechnology industry for nearly six years, I started my PhD program in Environmental Health Sciences in the Department of Medicine at the University of California, Irvine. Working in the lab of Charles Limoli, PhD, my focus was on mitigation of normal tissue toxicity in the brain via treatment with stem cell-derived extracellular vesicles in tumor-free mice. I defended his dissertation in late 2019 and went directly to Switzerland to work on ultra-high-dose-rate (FLASH) radiation with Dr. Vozenin. Indeed, my focus is still on limitation of normal tissue toxicity as he studies the FLASH effect from both the normal tissue and tumor perspectives mechanistically in vivo. I currently works with a multidisciplinary team concentrated on clinical translation of FLASH radiation modalities worldwide.